Global Duchenne Muscular Dystrophy Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 13, 2020 | 210 PAGES | REPORT CODE: CMM358942

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The Duchenne Muscular Dystrophy Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. The research provides insights for the global Duchenne Muscular Dystrophy Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Duchenne Muscular Dystrophy Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Duchenne Muscular Dystrophy Drugs Market Segmentations:

By Players:

Akashi Therapeutics Inc
Antisense Therapeutics Ltd
Beech Tree Labs Inc
Biogen Inc
Bioleaders Corp
BioMarin Pharmaceutical Inc
Biophytis SAS
Capricor Therapeutics Inc
Catabasis Pharmaceuticals Inc
CRISPR Therapeutics
Cumberland Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Debiopharm International SA
Editas Medicine Inc
Eloxx Pharmaceuticals Inc
F Hoffmann-La Roche Ltd
FibroGen Inc
Fulcrum Therapeutics Inc
Galapagos NV
Genethon SA
GTx Inc
Santhera Pharmaceuticals Holding AG
Sarepta Therapeutics Inc
SOM Biotech SL
Strykagen Corp
Summit Therapeutics Plc
Taiho Pharmaceutical Co Ltd
Teijin Pharma Ltd
WAVE Life Sciences Ltd

By Types:

Development & Drug Target
Mechanism of Action (MoA)
Route of Administration (RoA)
Molecule Type

By End-User:

Hospitals and Clinics
Medical Laboratories
Others

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Duchenne Muscular Dystrophy Drugs Market
1.3 Market Segmentation by Type

1.3.1 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Development & Drug Target from 2014 to 2026
1.3.2 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Mechanism of Action (MoA) from 2014 to 2026
1.3.3 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Route of Administration (RoA) from 2014 to 2026
1.3.4 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Molecule Type from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Hospitals and Clinics from 2014 to 2026
1.4.2 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Medical Laboratories from 2014 to 2026
1.4.3 Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Others from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Duchenne Muscular Dystrophy Drugs Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of Duchenne Muscular Dystrophy Drugs by Major Types

3.4.1 Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Development & Drug Target
3.4.2 Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Mechanism of Action (MoA)
3.4.3 Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Route of Administration (RoA)
3.4.4 Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Molecule Type

4 Segmentation of Duchenne Muscular Dystrophy Drugs Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of Duchenne Muscular Dystrophy Drugs by Major End-Users

4.4.1 Market Size and Growth Rate of Duchenne Muscular Dystrophy Drugs in Hospitals and Clinics
4.4.2 Market Size and Growth Rate of Duchenne Muscular Dystrophy Drugs in Medical Laboratories
4.4.3 Market Size and Growth Rate of Duchenne Muscular Dystrophy Drugs in Others

5 Market Analysis by Major Regions

5.1 Global Duchenne Muscular Dystrophy Drugs Production Analysis by Major Regions
5.2 Global Duchenne Muscular Dystrophy Drugs Consumption Analysis by Major Regions
5.3 Global Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
5.3.2 Europe Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Duchenne Muscular Dystrophy Drugs Market in Major Countries

6.1 Top 5 Export Countries in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019

6.2 Top 5 Import Countries in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America Duchenne Muscular Dystrophy Drugs Landscape Analysis

7.1 North America Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Types
7.2 North America Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major End-Users
7.3 North America Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Countries

7.3.1 United States Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
7.3.2 Canada Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
7.3.3 Mexico Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate

8 Europe Duchenne Muscular Dystrophy Drugs Landscape Analysis

8.1 Europe Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Types
8.2 Europe Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major End-Users
8.3 Europe Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Countries

8.3.1 Germany Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.2 UK Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.3 France Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.4 Italy Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.5 Nordic Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.6 Spain Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.7 Belgium Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.8 Poland Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.9 Russia Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
8.3.10 Turkey Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate

9 Asia Pacific Duchenne Muscular Dystrophy Drugs Landscape Analysis

9.1 Asia Pacific Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Types
9.2 Asia Pacific Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major End-Users
9.3 Asia Pacific Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Countries

9.3.1 China Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
9.3.2 Japan Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
9.3.3 Australia and New Zealand Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
9.3.4 India Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
9.3.5 ASEAN Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
9.3.6 South Korea Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Landscape Analysis

10.1 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Landscape Analysis by Major Countries

10.3.1 GCC Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
10.3.2 Brazil Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
10.3.3 Nigeria Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
10.3.4 South Africa Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate
10.3.5 Argentina Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate

11 Major Players Profile

11.1 Akashi Therapeutics Inc

11.1.1 Akashi Therapeutics Inc Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

11.2 Antisense Therapeutics Ltd

11.2.1 Antisense Therapeutics Ltd Company Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction

11.3 Beech Tree Labs Inc

11.3.1 Beech Tree Labs Inc Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction

11.4 Biogen Inc

11.4.1 Biogen Inc Company Profile and Recent Development
11.4.2 Market Performance
11.4.3 Product and Service Introduction

11.5 Bioleaders Corp

11.5.1 Bioleaders Corp Company Profile and Recent Development
11.5.2 Market Performance
11.5.3 Product and Service Introduction

11.6 BioMarin Pharmaceutical Inc

11.6.1 BioMarin Pharmaceutical Inc Company Profile and Recent Development
11.6.2 Market Performance
11.6.3 Product and Service Introduction

11.7 Biophytis SAS

11.7.1 Biophytis SAS Company Profile and Recent Development
11.7.2 Market Performance
11.7.3 Product and Service Introduction

11.8 Capricor Therapeutics Inc

11.8.1 Capricor Therapeutics Inc Company Profile and Recent Development
11.8.2 Market Performance
11.8.3 Product and Service Introduction

11.9 Catabasis Pharmaceuticals Inc

11.9.1 Catabasis Pharmaceuticals Inc Company Profile and Recent Development
11.9.2 Market Performance
11.9.3 Product and Service Introduction

11.10 CRISPR Therapeutics

11.10.1 CRISPR Therapeutics Company Profile and Recent Development
11.10.2 Market Performance
11.10.3 Product and Service Introduction

11.11 Cumberland Pharmaceuticals Inc

11.11.1 Cumberland Pharmaceuticals Inc Company Profile and Recent Development
11.11.2 Market Performance
11.11.3 Product and Service Introduction

11.12 Daiichi Sankyo Co Ltd

11.12.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development
11.12.2 Market Performance
11.12.3 Product and Service Introduction

11.13 Debiopharm International SA

11.13.1 Debiopharm International SA Company Profile and Recent Development
11.13.2 Market Performance
11.13.3 Product and Service Introduction

11.14 Editas Medicine Inc

11.14.1 Editas Medicine Inc Company Profile and Recent Development
11.14.2 Market Performance
11.14.3 Product and Service Introduction

11.15 Eloxx Pharmaceuticals Inc

11.15.1 Eloxx Pharmaceuticals Inc Company Profile and Recent Development
11.15.2 Market Performance
11.15.3 Product and Service Introduction

11.16 F Hoffmann-La Roche Ltd

11.16.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
11.16.2 Market Performance
11.16.3 Product and Service Introduction

11.17 FibroGen Inc

11.17.1 FibroGen Inc Company Profile and Recent Development
11.17.2 Market Performance
11.17.3 Product and Service Introduction

11.18 Fulcrum Therapeutics Inc

11.18.1 Fulcrum Therapeutics Inc Company Profile and Recent Development
11.18.2 Market Performance
11.18.3 Product and Service Introduction

11.19 Galapagos NV

11.19.1 Galapagos NV Company Profile and Recent Development
11.19.2 Market Performance
11.19.3 Product and Service Introduction

11.20 Genethon SA

11.20.1 Genethon SA Company Profile and Recent Development
11.20.2 Market Performance
11.20.3 Product and Service Introduction

11.21 GTx Inc

11.21.1 GTx Inc Company Profile and Recent Development
11.21.2 Market Performance
11.21.3 Product and Service Introduction

11.22 Santhera Pharmaceuticals Holding AG

11.22.1 Santhera Pharmaceuticals Holding AG Company Profile and Recent Development
11.22.2 Market Performance
11.22.3 Product and Service Introduction

11.23 Sarepta Therapeutics Inc

11.23.1 Sarepta Therapeutics Inc Company Profile and Recent Development
11.23.2 Market Performance
11.23.3 Product and Service Introduction

11.24 SOM Biotech SL

11.24.1 SOM Biotech SL Company Profile and Recent Development
11.24.2 Market Performance
11.24.3 Product and Service Introduction

11.25 Strykagen Corp

11.25.1 Strykagen Corp Company Profile and Recent Development
11.25.2 Market Performance
11.25.3 Product and Service Introduction

11.26 Summit Therapeutics Plc

11.26.1 Summit Therapeutics Plc Company Profile and Recent Development
11.26.2 Market Performance
11.26.3 Product and Service Introduction

11.27 Taiho Pharmaceutical Co Ltd

11.27.1 Taiho Pharmaceutical Co Ltd Company Profile and Recent Development
11.27.2 Market Performance
11.27.3 Product and Service Introduction

11.28 Teijin Pharma Ltd

11.28.1 Teijin Pharma Ltd Company Profile and Recent Development
11.28.2 Market Performance
11.28.3 Product and Service Introduction

11.29 WAVE Life Sciences Ltd

11.29.1 WAVE Life Sciences Ltd Company Profile and Recent Development
11.29.2 Market Performance
11.29.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 88 Figures and 187 Tables)

Figure Product Picture
Figure Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Development & Drug Target from 2014 to 2026
Figure Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Mechanism of Action (MoA) from 2014 to 2026
Figure Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Route of Administration (RoA) from 2014 to 2026
Figure Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Molecule Type from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Hospitals and Clinics from 2014 to 2026
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Medical Laboratories from 2014 to 2026
Figure Global Duchenne Muscular Dystrophy Drugs Market Size and Growth Rate of Others from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure France Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure China Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure India Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina Duchenne Muscular Dystrophy Drugs Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of Duchenne Muscular Dystrophy Drugs Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of Duchenne Muscular Dystrophy Drugs
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of Duchenne Muscular Dystrophy Drugs by Different Types from 2014 to 2026
Table Consumption Share of Duchenne Muscular Dystrophy Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Development & Drug Target
Figure Market Size and Growth Rate of Mechanism of Action (MoA)
Figure Market Size and Growth Rate of Route of Administration (RoA)
Figure Market Size and Growth Rate of Molecule Type
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of Duchenne Muscular Dystrophy Drugs by Different End-Users from 2014 to 2026
Table Consumption Share of Duchenne Muscular Dystrophy Drugs by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Hospitals and Clinics
Figure Market Size and Growth Rate of Medical Laboratories
Figure Market Size and Growth Rate of Others
Table Global Duchenne Muscular Dystrophy Drugs Production by Major Regions
Table Global Duchenne Muscular Dystrophy Drugs Production Share by Major Regions
Figure Global Duchenne Muscular Dystrophy Drugs Production Share by Major Regions in 2014
Figure Global Duchenne Muscular Dystrophy Drugs Production Share by Major Regions in 2018
Figure Global Duchenne Muscular Dystrophy Drugs Production Share by Major Regions in 2026
Table Global Duchenne Muscular Dystrophy Drugs Consumption by Major Regions
Table Global Duchenne Muscular Dystrophy Drugs Consumption Share by Major Regions
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Share by Major Regions in 2014
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Share by Major Regions in 2018
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Share by Major Regions in 2026
Table North America Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
Table Europe Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in Duchenne Muscular Dystrophy Drugs market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America Duchenne Muscular Dystrophy Drugs Consumption by Types from 2014 to 2026
Table North America Duchenne Muscular Dystrophy Drugs Consumption Share by Types from 2014 to 2026
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2014
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2018
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2026
Table North America Duchenne Muscular Dystrophy Drugs Consumption by End-Users from 2014 to 2026
Table North America Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users from 2014 to 2026
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2014
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2018
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2026
Table North America Duchenne Muscular Dystrophy Drugs Consumption by Major Countries from 2014 to 2026
Table North America Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries from 2014 to 2026
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2014
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2018
Figure North America Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2026
Figure United States Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Canada Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Mexico Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption by Types from 2014 to 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Types from 2014 to 2026
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2014
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2018
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption by End-Users from 2014 to 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users from 2014 to 2026
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2014
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2018
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption by Major Countries from 2014 to 2026
Table Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries from 2014 to 2026
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2014
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2018
Figure Europe Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2026
Figure Germany Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure UK Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure France Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Italy Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Belgium Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Poland Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Russia Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Turkey Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption by Types from 2014 to 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Types from 2014 to 2026
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2014
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2018
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption by End-Users from 2014 to 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2014
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2018
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption by Major Countries from 2014 to 2026
Table Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2014
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2018
Figure Asia Pacific Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2026
Figure China Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Japan Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandDuchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure India Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure South Korea Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Types in 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Drugs Consumption Share by Major Countries in 2026
Figure GCC Countries Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Brazil Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure South Africa Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Figure Argentina Duchenne Muscular Dystrophy Drugs Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Akashi Therapeutics Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Akashi Therapeutics Inc
Figure Sales and Growth Rate Analysis of Akashi Therapeutics Inc
Figure Revenue and Market Share Analysis of Akashi Therapeutics Inc
Table Product and Service Introduction of Akashi Therapeutics Inc
Table Company Profile and Development Status of Antisense Therapeutics Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Antisense Therapeutics Ltd
Figure Sales and Growth Rate Analysis of Antisense Therapeutics Ltd
Figure Revenue and Market Share Analysis of Antisense Therapeutics Ltd
Table Product and Service Introduction of Antisense Therapeutics Ltd
Table Company Profile and Development Status of Beech Tree Labs Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beech Tree Labs Inc
Figure Sales and Growth Rate Analysis of Beech Tree Labs Inc
Figure Revenue and Market Share Analysis of Beech Tree Labs Inc
Table Product and Service Introduction of Beech Tree Labs Inc
Table Company Profile and Development Status of Biogen Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Inc
Figure Sales and Growth Rate Analysis of Biogen Inc
Figure Revenue and Market Share Analysis of Biogen Inc
Table Product and Service Introduction of Biogen Inc
Table Company Profile and Development Status of Bioleaders Corp
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioleaders Corp
Figure Sales and Growth Rate Analysis of Bioleaders Corp
Figure Revenue and Market Share Analysis of Bioleaders Corp
Table Product and Service Introduction of Bioleaders Corp
Table Company Profile and Development Status of BioMarin Pharmaceutical Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMarin Pharmaceutical Inc
Figure Sales and Growth Rate Analysis of BioMarin Pharmaceutical Inc
Figure Revenue and Market Share Analysis of BioMarin Pharmaceutical Inc
Table Product and Service Introduction of BioMarin Pharmaceutical Inc
Table Company Profile and Development Status of Biophytis SAS
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biophytis SAS
Figure Sales and Growth Rate Analysis of Biophytis SAS
Figure Revenue and Market Share Analysis of Biophytis SAS
Table Product and Service Introduction of Biophytis SAS
Table Company Profile and Development Status of Capricor Therapeutics Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Capricor Therapeutics Inc
Figure Sales and Growth Rate Analysis of Capricor Therapeutics Inc
Figure Revenue and Market Share Analysis of Capricor Therapeutics Inc
Table Product and Service Introduction of Capricor Therapeutics Inc
Table Company Profile and Development Status of Catabasis Pharmaceuticals Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catabasis Pharmaceuticals Inc
Figure Sales and Growth Rate Analysis of Catabasis Pharmaceuticals Inc
Figure Revenue and Market Share Analysis of Catabasis Pharmaceuticals Inc
Table Product and Service Introduction of Catabasis Pharmaceuticals Inc
Table Company Profile and Development Status of CRISPR Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics
Figure Sales and Growth Rate Analysis of CRISPR Therapeutics
Figure Revenue and Market Share Analysis of CRISPR Therapeutics
Table Product and Service Introduction of CRISPR Therapeutics
Table Company Profile and Development Status of Cumberland Pharmaceuticals Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cumberland Pharmaceuticals Inc
Figure Sales and Growth Rate Analysis of Cumberland Pharmaceuticals Inc
Figure Revenue and Market Share Analysis of Cumberland Pharmaceuticals Inc
Table Product and Service Introduction of Cumberland Pharmaceuticals Inc
Table Company Profile and Development Status of Daiichi Sankyo Co Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd
Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd
Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd
Table Product and Service Introduction of Daiichi Sankyo Co Ltd
Table Company Profile and Development Status of Debiopharm International SA
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm International SA
Figure Sales and Growth Rate Analysis of Debiopharm International SA
Figure Revenue and Market Share Analysis of Debiopharm International SA
Table Product and Service Introduction of Debiopharm International SA
Table Company Profile and Development Status of Editas Medicine Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine Inc
Figure Sales and Growth Rate Analysis of Editas Medicine Inc
Figure Revenue and Market Share Analysis of Editas Medicine Inc
Table Product and Service Introduction of Editas Medicine Inc
Table Company Profile and Development Status of Eloxx Pharmaceuticals Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eloxx Pharmaceuticals Inc
Figure Sales and Growth Rate Analysis of Eloxx Pharmaceuticals Inc
Figure Revenue and Market Share Analysis of Eloxx Pharmaceuticals Inc
Table Product and Service Introduction of Eloxx Pharmaceuticals Inc
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
Table Company Profile and Development Status of FibroGen Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of FibroGen Inc
Figure Sales and Growth Rate Analysis of FibroGen Inc
Figure Revenue and Market Share Analysis of FibroGen Inc
Table Product and Service Introduction of FibroGen Inc
Table Company Profile and Development Status of Fulcrum Therapeutics Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fulcrum Therapeutics Inc
Figure Sales and Growth Rate Analysis of Fulcrum Therapeutics Inc
Figure Revenue and Market Share Analysis of Fulcrum Therapeutics Inc
Table Product and Service Introduction of Fulcrum Therapeutics Inc
Table Company Profile and Development Status of Galapagos NV
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galapagos NV
Figure Sales and Growth Rate Analysis of Galapagos NV
Figure Revenue and Market Share Analysis of Galapagos NV
Table Product and Service Introduction of Galapagos NV
Table Company Profile and Development Status of Genethon SA
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genethon SA
Figure Sales and Growth Rate Analysis of Genethon SA
Figure Revenue and Market Share Analysis of Genethon SA
Table Product and Service Introduction of Genethon SA
Table Company Profile and Development Status of GTx Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GTx Inc
Figure Sales and Growth Rate Analysis of GTx Inc
Figure Revenue and Market Share Analysis of GTx Inc
Table Product and Service Introduction of GTx Inc
Table Company Profile and Development Status of Santhera Pharmaceuticals Holding AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santhera Pharmaceuticals Holding AG
Figure Sales and Growth Rate Analysis of Santhera Pharmaceuticals Holding AG
Figure Revenue and Market Share Analysis of Santhera Pharmaceuticals Holding AG
Table Product and Service Introduction of Santhera Pharmaceuticals Holding AG
Table Company Profile and Development Status of Sarepta Therapeutics Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sarepta Therapeutics Inc
Figure Sales and Growth Rate Analysis of Sarepta Therapeutics Inc
Figure Revenue and Market Share Analysis of Sarepta Therapeutics Inc
Table Product and Service Introduction of Sarepta Therapeutics Inc
Table Company Profile and Development Status of SOM Biotech SL
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SOM Biotech SL
Figure Sales and Growth Rate Analysis of SOM Biotech SL
Figure Revenue and Market Share Analysis of SOM Biotech SL
Table Product and Service Introduction of SOM Biotech SL
Table Company Profile and Development Status of Strykagen Corp
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strykagen Corp
Figure Sales and Growth Rate Analysis of Strykagen Corp
Figure Revenue and Market Share Analysis of Strykagen Corp
Table Product and Service Introduction of Strykagen Corp
Table Company Profile and Development Status of Summit Therapeutics Plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Summit Therapeutics Plc
Figure Sales and Growth Rate Analysis of Summit Therapeutics Plc
Figure Revenue and Market Share Analysis of Summit Therapeutics Plc
Table Product and Service Introduction of Summit Therapeutics Plc
Table Company Profile and Development Status of Taiho Pharmaceutical Co Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taiho Pharmaceutical Co Ltd
Figure Sales and Growth Rate Analysis of Taiho Pharmaceutical Co Ltd
Figure Revenue and Market Share Analysis of Taiho Pharmaceutical Co Ltd
Table Product and Service Introduction of Taiho Pharmaceutical Co Ltd
Table Company Profile and Development Status of Teijin Pharma Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teijin Pharma Ltd
Figure Sales and Growth Rate Analysis of Teijin Pharma Ltd
Figure Revenue and Market Share Analysis of Teijin Pharma Ltd
Table Product and Service Introduction of Teijin Pharma Ltd
Table Company Profile and Development Status of WAVE Life Sciences Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of WAVE Life Sciences Ltd
Figure Sales and Growth Rate Analysis of WAVE Life Sciences Ltd
Figure Revenue and Market Share Analysis of WAVE Life Sciences Ltd
Table Product and Service Introduction of WAVE Life Sciences Ltd

REPORTS

Let’s Pullulate and Expand Your Business